New research is being presented at ASCO 2014, the American Society of Clinical Oncology’s annual meeting, from May 30 to June 3 in Chicago.
Meeting Highlights
Improving Prostate Cancer Screening
Pillars4Life Online Intervention Improves QOL in Cancer Patients
Discussing Clinical Trials With Lung & Colorectal Cancer Patients
Perceptions on Novel Prostate Cancer Technology
Assessing Mobile Apps in Oncology
Assessing Prostate Cancer Incidence Rates
Patients’ Actual Vs Preferred Decision-Making Roles
Tobacco Cessation in Cancer Patients
Second Malignancies After Prostate Cancer Treatment
Discussing Costs of Cancer Care Under the ACA
Practice Changing: Drug Preserves Fertility During Chemo
Low-Dose Radiation Okay in Some HPV-positive Head and Neck Cancers
Breast Cancer With Bone Mets: Less Zoledronic Acid Is Fine
Palliative Care: It’s for Caregivers Too, Says Study
Ramucirumab Hailed for Marginal Benefit in Lung Cancer
New Targeted Drug Highly Effective in Advanced Thyroid Cancer
Practice-Changing Results for Metastatic Prostate Cancer
ASCO Sounds Alarm on Declining Federally Funded Research
Bevacizumab, Cetuximab Have Similar Survival Benefits in CRC
Two Major Trials: AIs Work in Premenopausal Breast Cancer Too
Targeted Drug Combo Improves Outcomes in Ovarian Cancer
News From the Meeting
A ‘Home Run’ in Prostate Cancer Tx
Biologic Agents Plus Chemo Equal in Colon Ca
Aromasin Better for Young Breast Ca Survivors
Time to Change Lung Ca Surrogate Endpoint?
Lenvatinib Slows Resistant Thyroid Ca
Cyramza Boosts Survival in NSCLC
Ibrutinib Proves Its Mettle in CLL
OK to Cut Back on Bone Mets Therapy
Early Palliation in Ca Patients Eases Caregiver Burden
Drug Helps Save Fertility in Breast Ca
OK to Stop Statins in Terminal Illness
Myeloma Studies Presented at ASCO
50 Years of Progress, More to Come
More From ASCO 2014!
Registration and Hotel Information
Travel, Shuttle, & Chicago Information
